Evidence map›Paper›PMID 34707393›Full record

ArticleInternational journal of general medicine2021

High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcalá, Spain: Contributing Factors.

Ramón Pérez-Tanoira, Lourdes Lledó García, Miguel Torralba González de Suso, Manuel Rodríguez Zapata, Teresa Arroyo Serrano, Consuelo Giménez Pardo, María Isabel Rodríguez Pedrosa, Mª Nuria Romero Badía, Felipe Pérez-García, Patricia González López and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ramón Pérez-TanoiraDepartment of Biomedicine and Biotechnology, Alcalá University, Alcalá de Henares, Madrid, Spain.ORCID 0000-0002-9816-3208
Lourdes Lledó GarcíaDepartment of Biomedicine and Biotechnology, Alcalá University, Alcalá de Henares, Madrid, Spain.ORCID 0000-0001-5387-6792
Miguel Torralba González de SusoUnidad de Apoyo a Investigación de la Gerencia Integrada de Guadalajara, Guadalajara, Castilla-La Mancha, Spain.ORCID 0000-0003-2166-7405
Manuel Rodríguez ZapataDepartment of Medicine and Medical Specialties, Alcalá University, Guadalajara, Castilla-La Mancha, Spain.
Teresa Arroyo SerranoDepartment of Clinical Microbiology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Consuelo Giménez PardoDepartment of Biomedicine and Biotechnology, Alcalá University, Alcalá de Henares, Madrid, Spain.
María Isabel Rodríguez PedrosaServicio de Prevencion, Alcalá University, Alcalá de Henares, Madrid, Spain.
Mª Nuria Romero BadíaServicio de Prevencion, Alcalá University, Alcalá de Henares, Madrid, Spain.
Felipe Pérez-GarcíaDepartment of Biomedicine and Biotechnology, Alcalá University, Alcalá de Henares, Madrid, Spain.ORCID 0000-0002-4885-4334
Patricia González LópezServicio de Prevencion, Alcalá University, Alcalá de Henares, Madrid, Spain.
Cristina Villaescusa GarcíaServicio de Prevencion, Alcalá University, Alcalá de Henares, Madrid, Spain.
Juan Cuadros GonzálezDepartment of Biomedicine and Biotechnology, Alcalá University, Alcalá de Henares, Madrid, Spain.
Universidad de Alcalá · ESHospital Universitario Príncipe de Asturias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeroprevalence against SARS-CoV-2 within university systems is poorly studied, making evidence-based discussions of educational system reopening difficult. Moreover, few studies evaluate how antibodies against SARS-CoV-2 are maintained over time. We assessed serological response against the SARS-CoV-2 virus among our university students and staff. PATIENTS AND

methodsIn this prospective cohort study, seroprevalence was determined in 705 randomly selected volunteers, members of the Faculty of Medicine and Health Sciences of the University of Alcalá, using a chemiluminescent Siemens' SARS-CoV-2 immunoassay for total antibodies. Positive samples were tested for IgG and IgM/IgA using VIRCLIA

resultsA total of 130 subjects showed anti-SARS-CoV-2 antibodies (18.5%, 95% CI, 15.8-21.5%). Of these, IgM/IgA was positive in 27 and indeterminate in 19; IgG was positive in 118, indeterminate in 1. After 23 weeks, among 102 volunteers remeasured, IgG became undetectable in 6. Presence of antibodies was associated, in multivariable logistic regression, with exposure to infected patients (31.3%) [OR 1.84, 95% CI, 1.14-2.96; P = 0.012], presence of COVID-19 symptoms (52.4%) [OR 6.88, 95% CI, 4.28-11.06; P < 0.001], and confirmed earlier infection (82.9%) [OR 11.87, 95% CI, 4.26-33.07; P < 0.001].

conclusionsThe faculty of medicine and health sciences personnel and students of our university showed a high infection rate for SARS-CoV-2 during 2020 associated with providing clinical care to infected patients. This emphasizes the importance of the performance of continuous surveillance methods of the most exposed health personnel, including health science students.

Indexed as

COVID-19degree of health scienciesSARS-CoV-2seroprevalenceuniversity

Identifiers

PMID34707393
PMCPMC8544125
OpenAlexW3206856784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.